Efficacious topical treatment for human cutaneous leishmaniasis with ethanolic lipid amphotericin B

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 95, Issue 2, 2001, Pages 184-186

  Vardy, Daniel ^a   Barenholz, Yechezkel ^b   Naftoliev, Natalia ^a   Klaus, Sidney ^c   Gilead, Leon ^c   Frankenburg, Shoshana ^c  

^a CLALIT HEALTH SERVICES   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Amphotericin B; Chemotherapy; Cutaneous leishmaniasis; Israel; Leishmania major; Topical treatment

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; ANTIMONY DERIVATIVE; KETOCONAZOLE; PAROMOMYCIN; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; LEISHMANIA; SINGLE BLIND PROCEDURE; SKIN LEISHMANIASIS; STATISTICAL ANALYSIS; TREATMENT OUTCOME; WOUND HEALING;

LEISHMANIA MAJOR;

EID: 0035295413     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(01)90158-0     Document Type: Article

References (6)

1. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment
2. Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methyl-benzethonium chloride
3. Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B
4. Leishmaniasis and other protozoan infections
5. Changing patterns of cutaneous leishmaniasis in Israel
6. Topical amphotericin B for cutaneous leishmaniasis